Nursing home ‘avoidable transfer scale’ prevents unnecessary transitions in pilot study
By
Alicia Lasek (f3)
Jul 18, 2022
A tool called the Avoidable Transfer Scale enables nursing homes to outsource quality improvement work related to potentially avoidable hospitalizations, researchers say.
What is the best post-acute care destination for an assisted living resident? It’s complicated, new...
By
Alicia Lasek
Jan 31, 2022
Acute care clinicians and discharge planners need more complete information about LTC services and target populations to help ensure that residents land in the most appropriate settings, researchers say.
Antibiotic overkill leads to widespread side effects such as C. diff, large study finds
By
Alicia Lasek
Apr 02, 2023
“We’re talking about hundreds of thousands of adverse events severe enough that these patients needed additional care from a doctor,” an investigator said.
FDA no longer requires positive COVID-19 test to prescribe Paxlovid, Lagevrio
By
Alicia Lasek
Feb 01, 2023
The FDA on Wednesday made it easier for clinicians to prescribe these antiviral drugs in cases where transmission is evident and the patient is at high risk of severe illness.
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
Seniors have fewer chemotherapy side effects with supportive care program, clinical trial finds
By
Alicia Lasek
Oct 01, 2021
Patients in the intervention group experienced a 10% reduction in moderate side effects — without significant chemotherapy modifications or dose reductions, investigators say.
Feds halt an Eli Lilly antibody therapy in 3 states due to variant fears, while boosting the treatment...
By
Alicia Lasek
Mar 19, 2021
A COVID-19 variant circulating widely in California, Arizona and Nevada has rendered bamlanivimab alone ineffective, an FDA official reports. But Lilly says an approved alternative treatment “maintains...
Surgeon general tags loneliness as next public health threat
By
Alicia Lasek
May 03, 2023
The U.S. surgeon general on Tuesday declared loneliness, a condition linked to health comorbidities and premature death, an American epidemic requiring national action.
Lack of knowledge on osteoporosis is widespread, may lead to undertreatment, investigators find
By
Alicia Lasek
Jun 08, 2023
Despite experiencing fractures attributable to osteoporosis, many women in a study had not undergone screening for the disease, researchers say.